- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Gillian M. Russell
Events 21 results
Speaking Engagement
February 23, 2023
Nikki Reeves, Heather Banuelos, Gillian Russell to Speak at DIA Global’s Advertising and Promotion Regulatory Affairs Conference
Speaking Engagement
February 23, 2023
Gillian Russell to Speak at DIA’s Advertising and Promotion Regulatory Affairs Conference
Webinar
January 24, 2023
Year in Review for Drug and Device Advertising and Promotion: Lessons Learned From 2022 FDA Enforcement Letters and Other Key Developments
Conference
November 1, 2022
Pharmaceutical University 2022
Speaking Engagement
June 29, 2022
Heather Banuelos, Gillian Russell to Speak at Food and Drug Law Institute’s Introduction to Drug Law and Regulation Course
Webinar
January 25, 2022
2021 Year in Review for Drug and Device Advertising and Promotion – Lessons Learned From FDA Enforcement Letters and Other Key Developments
Speaking Engagement
November 11, 2021
Heather Bañuelos, Gillian Russell to Speak at Food and Drug Law Institute’s Introduction to Drug Law Regulation Conference
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Speaking Engagement
October 14, 2021
Gillian Russell to Speak at Food and Drug Law Institute’s Advertising and Promotion for Medical Products Conference
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Speaking Engagement
May 26, 2021
Heather Bañuelos, Gillian Russell to Co-Present OPDP & FTC Enforcement Trends Webinar